Tirzee™ (Tirzepatide)

Tirzee™ (Tirzepatide) is a once-weekly injectable treatment used alongside a healthy diet and physical activity to:

• Help adults with Type 2 Diabetes improve blood sugar control.
• Support weight loss and long-term weight management in adults living with obesity or overweight with weight-related health conditions.
• Reduce the risk of certain cardiovascular (heart-related) events in eligible adults with Type 2 Diabetes.
• Help manage moderate to severe Obstructive Sleep Apnea (OSA) in adults with obesity.

Tirzee™ contains Tirzepatide, which works by activating two natural hormone pathways called GIP and GLP-1 receptors. These help:

• Improve insulin release when blood sugar levels are high.
• Reduce the amount of sugar produced by the body.
• Slow stomach emptying, helping you feel fuller for longer.
• Support appetite control, which can help reduce calorie intake and promote weight loss.

• Tirzee is administered as a subcutaneous injection (under the skin) once weekly.
• The usual starting dose is 2.5 mg once weekly for the first 4 weeks.
• After 4 weeks, the dose is typically increased to 5 mg once weekly.
• If needed, your healthcare provider may gradually increase the dose based on your response and tolerance.
• The maximum recommended dose is 15 mg once weekly.
• It can be injected in the abdomen, thigh, or upper arm.
• Tirzee can be taken with or without meals.
• Rotate injection sites with each dose.

Before using Tirzee, inform your healthcare provider about all medicines you take.

Special attention is needed if you use:

• Insulin or sulfonylurea medicines, as the risk of low blood sugar (hypoglycemia) may increase.
• Oral medications, since Tirzee may slow stomach emptying and affect how some medicines are absorbed.
• Oral hormonal contraceptives (birth control pills). Additional or alternative contraceptive methods may be recommended for 4 weeks after starting treatment and after each dose increase.

Do not use Tirzee if:

• You are allergic to Tirzepatide or any of its ingredients.
• You or a family member has a history of Medullary Thyroid Carcinoma (MTC).
• You have Multiple Endocrine Neoplasia Syndrome Type 2 (MEN 2). [Tirzee-4-Leaflet | PDF]

Important Safety Considerations

• Contact your healthcare provider immediately if you experience severe abdominal pain, which may indicate pancreatitis.
• Common side effects may include nausea, diarrhea, vomiting, constipation, reduced appetite, abdominal discomfort, and fatigue.
• The risk of low blood sugar may increase when used with insulin or certain diabetes medications.
• Tell your healthcare provider if you are pregnant, planning pregnancy, or breastfeeding.
• Use only as prescribed by a qualified healthcare professional. [Tirzee-4-Leaflet | PDF]

Estimated delivery time is 24-48 hours for major cities.
* Delivery to other areas may vary.